The phencyclidine model of schizophrenia: basic mechanisms

被引：0
|
作者：
Svensson, TH [1 ]
机构：
[1] Karolinska Inst, Sect Neuropsychopharmacol, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [41] Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia
    Liu, F.
    Zou, X.
    Sadovova, N.
    Zhang, X.
    Shi, L.
    Guo, L.
    Qian, F.
    Wen, Z.
    Patterson, T. A.
    Hanig, J. P.
    Paule, M. G.
    Slikker, W., Jr.
    Wang, C.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2011, 29 (03) : 351 - 358
  • [42] EFFECTS OF ANTIPSYCHOTICS ON THE BONE MINERAL DENSITY, CORTISOL AND PROINFLAMMATORY CYTOKINES IN PHENCYCLIDINE ANIMAL MODEL OF SCHIZOPHRENIA
    Petronijevic, N.
    Nikolic, T.
    Sopta, J.
    Velimirovic, M.
    Dozudic, G. Fevtic
    Stojkovic, T.
    Zivkovic, M.
    Petronijevic, M.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S559 - S559
  • [43] Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition
    Xiao, Xiaolin
    Dawson, Neil
    MacIntyre, Lynsey
    Morris, Brian J.
    Pratt, Judith A.
    Watson, David G.
    Higham, Desmond J.
    BMC SYSTEMS BIOLOGY, 2011, 5
  • [44] The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia
    Sanna K. Janhunen
    Heta Svärd
    John Talpos
    Gaurav Kumar
    Thomas Steckler
    Niels Plath
    Linda Lerdrup
    Trine Ruby
    Marie Haman
    Roger Wyler
    Theresa M. Ballard
    Psychopharmacology, 2015, 232 : 4059 - 4083
  • [45] ENHANCEMENT OF IMMOBILITY IN A FORCED SWIMMING TEST BY SUBACUTE OR REPEATED TREATMENT WITH PHENCYCLIDINE - A NEW MODEL OF SCHIZOPHRENIA
    NODA, Y
    YAMADA, K
    FURUKAWA, H
    NABESHIMA, T
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (05) : 2531 - 2537
  • [46] A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging
    Broberg, Brian V.
    Madsen, Kristoffer H.
    Plath, Niels
    Olsen, Christina K.
    Glenthoj, Birte Y.
    Paulson, Olaf B.
    Bjelke, Borje
    Sogaard, Lise V.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 250 : 1 - 8
  • [47] Baseline temperature in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration
    Radonjic, Nevena V.
    Petronijevic, Natasa D.
    Vuckovic, Sonja M.
    Prostran, Milica S.
    Nesic, Zorica I.
    Todorovic, Veljko R.
    Paunovic, Vladimir R.
    PHYSIOLOGY & BEHAVIOR, 2008, 93 (03) : 437 - 443
  • [48] Increased translocator protein (TSPO) binding throughout neurodevelopment in the perinatal phencyclidine rodent model of schizophrenia
    Lum, Jeremy S.
    du Bois, Teresa M.
    Mattner, Filomena
    Katsifis, Andrew
    Brown, Samara J.
    Huang, Xu-Feng
    Newell, Kelly A.
    SCHIZOPHRENIA RESEARCH, 2019, 212 : 243 - 245
  • [49] Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia
    Santini, Martin A.
    Ratner, Cecilia
    Aznar, Susana
    Klein, Anders B.
    Knudsen, Gitte M.
    Mikkelsen, Jens D.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2013, 91 (05) : 634 - 641
  • [50] CHARACTERIZATION OF EARLY POSTNATAL PHENCYCLIDINE TREATMENT AS AN ANIMAL MODEL OF SCHIZOPHRENIA BY PHARMACOLOGICAL MAGNETIC RESONANCE IMAGING
    Broberg, Brian V.
    Madsen, Kristoffer H.
    Plath, Niels
    Olsen, Christina K.
    Glenthoj, Birte Y.
    Paulson, Olaf B.
    Bjelke, Borje
    Sogaard, Lise V.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 132 - 132
12345